News
STAT | New study raises questions about early-stage cancer therapies for children
Published: 21 February 2018
At this early stage, the potential for harm is real while the benefits are only surrogate measures, said Kimmelman, an associate professor of biomedical ethics at 捆绑SM社区. One such measure at Phase 1 might be tumor shrinkage, which does not necessarily translate into what people really care about: survival.